The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase I/IIa study to evaluate the safety and efficacy of SNK01 (non-genetically modified autologous natural killer cells with enhanced cytotoxicity) plus pembrolizumab in patients with stage IV non-small cell lung cancer.
 
Eo Jin Kim
No Relationships to Disclose
 
Dae-Hyun Ko
No Relationships to Disclose
 
Wonjun Ji
No Relationships to Disclose
 
Jin Kyung Rho
No Relationships to Disclose
 
Jae Cheol Lee
No Relationships to Disclose
 
Paul Y. Song
Employment - NKMax
Leadership - NKMax
Stock and Other Ownership Interests - NKMax
Travel, Accommodations, Expenses - NKMax
 
Chang-Min Choi
Employment - Procuratio
Stock and Other Ownership Interests - Procuratio